148 related articles for article (PubMed ID: 8690562)
1. A multinational economic evaluation of rhDNase in the treatment of cystic fibrosis.
Menzin J; Oster G; Davies L; Drummond MF; Greiner W; Lucioni C; Merot JL; Rossi F; vd Schulenburg JG; Souêtre E
Int J Technol Assess Health Care; 1996; 12(1):52-61. PubMed ID: 8690562
[TBL] [Abstract][Full Text] [Related]
2. rhDNase therapy for the treatment of cystic fibrosis patients with mild to moderate lung disease.
Christopher F; Chase D; Stein K; Milne R
J Clin Pharm Ther; 1999 Dec; 24(6):415-26. PubMed ID: 10651974
[TBL] [Abstract][Full Text] [Related]
3. Effects of recombinant human DNase therapy on healthcare use and costs in patients with cystic fibrosis.
Oster G; Huse DM; Lacey MJ; Regan MM; Fuchs HJ
Ann Pharmacother; 1995 May; 29(5):459-64. PubMed ID: 7655127
[TBL] [Abstract][Full Text] [Related]
4. rhDNase in cystic fibrosis.
Tyrrell JC; Lewis PA; Sheldon CD; Connett G
Thorax; 1999 Aug; 54(8):752. PubMed ID: 10490419
[No Abstract] [Full Text] [Related]
5. Recombinant human DNase (rhDNase) in cystic fibrosis: is it cost effective?
Conway SP
Arch Dis Child; 1997 Jul; 77(1):1-3. PubMed ID: 9279142
[No Abstract] [Full Text] [Related]
6. [Socioeconomic evaluation of the effect of rhDNase on the cost of treating infections of the respiratory tract in patients with cystic fibrosis].
von der Schulenburg JM; Greiner W; von der Hardt H
Med Klin (Munich); 1995 Apr; 90(4):220-4. PubMed ID: 7776934
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human deoxyribonuclease for cystic fibrosis.
Jones AP; Wallis CE
Cochrane Database Syst Rev; 2003; (3):CD001127. PubMed ID: 12917899
[TBL] [Abstract][Full Text] [Related]
8. Use of rhDNase therapy and costs of respiratory-related care in patients with cystic fibrosis.
Ollendorf DA; McGarry LJ; Watrous ML; Oster G
Ann Pharmacother; 2000 Mar; 34(3):304-8. PubMed ID: 10917374
[TBL] [Abstract][Full Text] [Related]
9. Dornase alfa. A review of pharmacoeconomic and quality-of-life aspects of its use in cystic fibrosis.
Goa KL; Lamb H
Pharmacoeconomics; 1997 Sep; 12(3):409-22. PubMed ID: 10170464
[TBL] [Abstract][Full Text] [Related]
10. Multicenter, open-label study of recombinant human DNase in cystic fibrosis patients with moderate lung disease. DNase International Study Group.
Harms HK; Matouk E; Tournier G; von der Hardt H; Weller PH; Romano L; Heijerman HG; FitzGerald MX; Richard D; Strandvik B; Kolbe J; Kraemer R; Michalsen H
Pediatr Pulmonol; 1998 Sep; 26(3):155-61. PubMed ID: 9773909
[TBL] [Abstract][Full Text] [Related]
11. Comment: cost of rhDNase in cystic fibrosis.
Marra CA; Carleton BC; Basmadjian D; Levine M; McKerrow R
Ann Pharmacother; 1995 Oct; 29(10):1050-1. PubMed ID: 8845550
[No Abstract] [Full Text] [Related]
12. The role of dornase alfa in the treatment of cystic fibrosis.
Cramer GW; Bosso JA
Ann Pharmacother; 1996 Jun; 30(6):656-61. PubMed ID: 8792953
[TBL] [Abstract][Full Text] [Related]
13. Aerosolized dornase alpha (rhDNase) in cystic fibrosis.
Bates RD; Nahata MC
J Clin Pharm Ther; 1995 Dec; 20(6):313-5. PubMed ID: 8847368
[TBL] [Abstract][Full Text] [Related]
14. Effects of hypertonic saline, alternate day and daily rhDNase on healthcare use, costs and outcomes in children with cystic fibrosis.
Suri R; Grieve R; Normand C; Metcalfe C; Thompson S; Wallis C; Bush A
Thorax; 2002 Oct; 57(10):841-6. PubMed ID: 12324668
[TBL] [Abstract][Full Text] [Related]
15. A cost-effectiveness analysis of rhDNase in children with cystic fibrosis.
Grieve R; Thompson S; Normand C; Suri R; Bush A; Wallis C
Int J Technol Assess Health Care; 2003; 19(1):71-9. PubMed ID: 12701940
[TBL] [Abstract][Full Text] [Related]
16. Comment: cost of rhDNase in cystic fibrosis.
Bates RD; Nahata MC
Ann Pharmacother; 1995 Oct; 29(10):1051. PubMed ID: 8845551
[No Abstract] [Full Text] [Related]
17. Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial.
Suri R; Metcalfe C; Lees B; Grieve R; Flather M; Normand C; Thompson S; Bush A; Wallis C
Lancet; 2001 Oct; 358(9290):1316-21. PubMed ID: 11684212
[TBL] [Abstract][Full Text] [Related]
18. Dornase alfa: a new option in the management of cystic fibrosis.
Witt DM; Anderson L
Pharmacotherapy; 1996; 16(1):40-8. PubMed ID: 8700791
[TBL] [Abstract][Full Text] [Related]
19. Aerosolized recombinant human DNase I for the treatment of cystic fibrosis.
Shak S
Chest; 1995 Feb; 107(2 Suppl):65S-70S. PubMed ID: 7842816
[TBL] [Abstract][Full Text] [Related]
20. rhDNase in cystic fibrosis.
Range SP; Knox AJ
Thorax; 1995 Apr; 50(4):321-2. PubMed ID: 7785000
[No Abstract] [Full Text] [Related]
[Next] [New Search]
